Notice of Final Results
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, will announce its results for the year ended 30 April 2024 on Tuesday 24 September 2024.
Professor Lindy Durrant, Chief Executive Officer, and Sath Nirmalananthan, Chief Financial Officer, will host a virtual analyst briefing at 13:00 BST on the day of the results. There will also be a live webcast and conference call with a Q&A session. The webcast will be shared on the Investor Relations section of the Company's website at https://scancell.co.uk/.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.